Thursday, February 27, 2014

Polio-Like Syndrome Surfaces in California

Reports of a puzzling polio-like syndrome affecting children in northern California have launched something of media frenzy.
Emmanuelle Waubant, MD, PhD, professor, clinical neurology and pediatrics, University of California at San Francisco (UCSF), said she was surprised by all the attention to this case series, and believes it's because the cases are linked to "children" and "polio," 2 words that set off alarms when used together.
To date, Dr. Waubant and her colleagues have identified 5 children, aged 2 to 16 years, who presented with acute onset of flaccid paralysis affecting 1 or more limbs that reached peak severity within 48 hours of onset. MRI showed non enhancing T2 hyperintensities of the central gray matter; cerebral spinal fluid was normal, albeit mildly pleocytotic.
The cases will be presented at the upcoming 66th Annual Meeting of the American Academy of Neurology (AAN) in Philadelphia, April 26 to May 3.
Doctors initially suspected transverse myelitis, an inflammation of the spinal cord that may cause paralysis, but lack of sensory changes and other telltale neurologic symptoms, plus a negative workup, ruled out this diagnosis, said Dr. Waubant. They also excluded Guillain-Barré syndrome and botulism.
   

Three of the youngsters had prodromal respiratory illness before their paralysis, which, said Dr. Waubant, "is probably significant." Poliovirus has been eradicated from most of the globe, but other viruses can also injure the lower motor neurons of the spine, leading to a polio-like syndrome.
So far, 2 cases have tested positive for the enterovirus-68, a rare virus that in the past has been associated with polio-like syndrome.
"In the case of an enterovirus, you can have a cold-like presentation," said Dr. Waubant. "We think that if it's a virus [responsible for the symptoms presented], it's probably a virus that is not responsible for paralysis in every single patient that is affected, only in specific patients that have the right biological makeup."
Children Vaccinated
Although the disorder "looks clinically like polio," polio itself was also ruled out because all the children had been vaccinated against the polio virus. "All the cases had a good level of antibodies so they could not be infected with the polio virus," said Dr. Waubant.
There's nothing really to tie these children together except for their clinical presentation. "They had nothing in common," said Dr. Waubant. "It's not a cluster because they came from different areas," although they were from within a 100-mile radius of each other in northern California.
Treatment with steroids, intravenous immunoglobulin, and/or plasma exchange did not appear to have a clinical benefit, with motor function recovery at 6 months described as being poor. "The children have remained quite disabled," she said. "Some have recovered a little bit but the improvement has been from zero to marginal."

Wednesday, February 26, 2014

Fever During Pregnancy Linked to Birth Defects

Fever during pregnancy may harm offspring health, according to a study published online February 24 in Pediatrics.
Studies in several mammalian models have associated first trimester exposure to elevated maternal temperature with damage to the extra embryonic membranes, placenta, and maternal–fetal circulation, resulting in growth retardation, malformations, and fetal demise, and in the longer-term, to impaired cognitive function. The extent to which these experimental conditions mimic human  prenatal exposures was not clear.
One in 5 women reports fever during pregnancy, but few investigations have systematically examined the outcomes on child health. Therefore, Julie Werenberg Dreier, MSPH, doctoral candidate at the Institute of Public Health, University of Southern Denmark, Esbjerg, and colleagues reviewed evidence from epidemiologic studies to assess the relationship between fetal exposure to maternal fever and health outcomes.
They reviewed 46 cohort or case-control investigations reported in PubMed, Web of Science, and the Cochrane Library that mentioned maternal fever in general populations during the first trimester or preconceptually. They also included some studies referenced within the initially examined ones.
The analysis revealed elevated risk for poor health outcomes among children exposed to maternal fever in utero for 3 common classes of problems: neural tube defects, congenital heart defects, and oral clefts. The researchers identified a 1.5- to nearly 3-fold increased risk with exposure during the first trimester for 9 case-control studies of neural tube defects, 5 case-control studies of oral clefts, and 7 fixed-effects meta analyses of congenital heart defects.
Neural tube defects had the strongest relationship to temperature exposure (odds ratio [OR] pooled, 2.90; 95% confidence interval [CI], 2.22 - 3.79) compared with oral clefts (OR pooled, 1.94; 95% CI, 1.35 - 2.79) and congenital heart defects (OR
Other outcomes included limb deficiencies, renal defects, anorectal malformation, ear defects, cataracts, and allergic diseases, but few studies were available. The analysis did not find an association between exposure to elevated maternal temperature in utero with spontaneous abortion, stillbirth, or preterm delivery.
Only some studies investigated correlations between magnitude of elevated temperature and outcomes; they did not find any. Some studies showed lowered risk with use of antipyretic medication.
The researchers conclude that they "found substantial evidence to support an adverse impact of maternal fever during pregnancy." They suggest that future studies be conducted prospectively, assess longer-term health outcomes, and consider timing, duration, and extent of fever.
Limitations of the study include the consideration of elevated maternal temperature and not the underlying cause of it (type of infection). The review might also reflect publication bias and heterogeneity among the considered studies (such as prospective vs retrospective).

Saturday, February 15, 2014

PROTOCOL ON SEVERE PIH

Order Set for Severe Intrapartum or Postpartum Hypertension
Initial First-Line Management with Labetalol*
  1. Notify physician if systolic BP measurement is greater than or equal to 160 mm Hg or if diastolic BP measurement is greater than or equal to 110 mm Hg.
  2. Institute fetal surveillance if undelivered and fetus is viable.
  3. Administer labetalol (20 mg IV over 2 minutes).
  4. Repeat BP measurement in 10 minutes and record results.
  5. If either BP threshold is still exceeded, administer labetalol (40 mg IV over 2 minutes). If BP is below threshold, continue to monitor BP closely.
  6. Repeat BP measurement in 10 minutes and record results.
  7. If either BP threshold is still exceeded, administer labetalol (80 mg IV over 2 minutes). If BP is below threshold, continue to monitor BP closely.
  8. Repeat BP measurement in 10 minutes and record results.
  9. If either BP threshold is still exceeded, administer hydralazine (10 mg IV over 2 minutes). If BP is below threshold, continue to monitor BP closely.
  10. Repeat BP measurement in 20 minutes and record results.
  11. If either BP threshold is still exceeded, obtain emergency consultation from maternal–fetal medicine, internal medicine, anesthesia, or critical care specialists.
  12. Give additional antihypertensive medication per specific order.
  13. Once the aforementioned BP thresholds are achieved, repeat BP measurement every 10 minutes for 1 hour, then every 15 minutes for 1 hour, then every 30 minutes for 1 hour, and then every hour for 4 hours.
  14. Institute additional BP timing per specific order.
Abbreviations: BP, blood pressure; IV, intravenously.
*See text for important adverse effects and contraindications.

Data from Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.
Order Set for Severe Intra partum or Postpartum Hypertension
Initial First-Line Management with Hydralazine*
  1. Notify physician if systolic BP is greater than or equal to 160 mm Hg or if diastolic BP is greater than or equal to 110 mm Hg.
  2. Institute fetal surveillance if undelivered and fetus is viable.
  3. Administer hydralazine (5 mg or 10 mg IV over 2 minutes).
  4. Repeat BP measurement in 20 minutes and record results.
  5. If either BP threshold is still exceeded, administer hydralazine (10 mg IV over 2 minutes). If BP is below threshold, continue to monitor BP closely.
  6. Repeat BP measurement in 20 minutes and record results.
  7. If either BP threshold is still exceeded, administer labetalol (20 mg IV over 2 minutes). If BP is below threshold, continue to monitor BP closely.
  8. Repeat BP measurement in 10 minutes and record results.
  9. If either BP threshold is still exceeded, administer labetalol (40 mg IV over 2 minutes) and obtain emergency consultation from maternal–fetal medicine, internal medicine, anesthesia, or critical care specialists.
  10. Give additional antihypertensive medication per specific order.
  11. Once the aforementioned BP thresholds are achieved,repeat BP measurement every 10 minutes for 1 hour,then every 15 minutes for 1 hour, then every 30 minutes for 1 hour, and then every hour for 4 hours.
  12. Institute additional BP timing per specific order.
Abbreviations: BP, blood pressure; IV, intravenously.
*See text for important adverse effects and contraindications.
Data from Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.

Thursday, February 13, 2014

New guidelines for stroke prevention, especially in women

The American Heart Association has issued new guidelines for the prevention of strokes, specifically in women, and published them in "Stroke". While many risk factors are the same among both sexes, hormones, reproductive health and pregnancy play an important role in women, emphasised author Cheryl Bushnell from the Wake Forest Baptist Medical Center in Winston-Salem (North Carolina).
According to the guidelines, women who suffer from high blood pressure before pregnancy should be considered for treatment with low-dose aspirin and/or a calcium supplement to decrease the risk of preeclampsia. In later life, preeclampsia doubles the risk of stroke and quadruples the risk of high blood pressure. Therefore, early treatment of factors such as obesity and high cholesterol is recommended for women who had experienced preeclampsia.
The guidelines state that treatment is strongly recommended for women suffering from high blood pressure during pregnancy, and a therapy should be considered for those with moderately high blood pressure (150-159 mmHg/100-109 mmHg). The authors recommend that women with high blood pressure should not take birth control pills, because this combination could increase the risk of developing a stroke.
Increased attention is indicated in women who smoke and who suffer from migraine with aura. Over 75 year-olds should be screened for atrial fibrillation as this, likewise, increases the risk, said the physicians.